Quick Answer
Inmune Bio, Inc. reported Long Term Debt of $9.70 million for the year ending 2022.
- This data is from Inmune Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2024.
- XBRL data for this metric is available from 2022 to 2022 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: